TY - JOUR
T1 - 2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad
T2 - 1st international conference held in San Francisco, CA, May 2012, and 2nd international conference held in Indianapolis, IN, May 2013
AU - De Souza, Mary Jane
AU - Nattiv, Aurelia
AU - Joy, Elizabeth
AU - Misra, Madhusmita
AU - Williams, Nancy I.
AU - Mallinson, Rebecca J.
AU - Gibbs, Jenna C.
AU - Olmsted, Marion
AU - Goolsby, Marci
AU - Matheson, Gordon
PY - 2014/3
Y1 - 2014/3
N2 - The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. Female athletes often present with 1 or more of the 3 Triad components, and an early intervention is essential to prevent its progression to serious endpoints that include clinical eating disorders, amenorrhea, and osteoporosis. This consensus statement represents a set of recommendations developed following the first (San Francisco, California) and second (Indianapolis, Indianna) International Symposia on the Female Athlete Triad. It is intended to provide clinical guidelines for physicians, athletic trainers, and other health care providers for the screening, diagnosis, and treatment of the Female Athlete Triad and to provide clear recommendations for return to play. The 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad Expert Panel has proposed a risk stratification point system that takes into account magnitude of risk to assist the physician in decision-making regarding sport participation, clearance, and return to play. Guidelines are offered for clearance categories, management by a multidisciplinary team, and implementation of treatment contracts. This consensus paper has been endorsed by The Female Athlete Triad Coalition, an International Consortium of leading Triad researchers, physicians, and other health care professionals, the American College of Sports Medicine, and the American Medical Society for Sports Medicine.
AB - The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. Female athletes often present with 1 or more of the 3 Triad components, and an early intervention is essential to prevent its progression to serious endpoints that include clinical eating disorders, amenorrhea, and osteoporosis. This consensus statement represents a set of recommendations developed following the first (San Francisco, California) and second (Indianapolis, Indianna) International Symposia on the Female Athlete Triad. It is intended to provide clinical guidelines for physicians, athletic trainers, and other health care providers for the screening, diagnosis, and treatment of the Female Athlete Triad and to provide clear recommendations for return to play. The 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad Expert Panel has proposed a risk stratification point system that takes into account magnitude of risk to assist the physician in decision-making regarding sport participation, clearance, and return to play. Guidelines are offered for clearance categories, management by a multidisciplinary team, and implementation of treatment contracts. This consensus paper has been endorsed by The Female Athlete Triad Coalition, an International Consortium of leading Triad researchers, physicians, and other health care professionals, the American College of Sports Medicine, and the American Medical Society for Sports Medicine.
UR - http://www.scopus.com/inward/record.url?scp=84896718155&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896718155&partnerID=8YFLogxK
U2 - 10.1097/JSM.0000000000000085
DO - 10.1097/JSM.0000000000000085
M3 - Article
C2 - 24569429
AN - SCOPUS:84896718155
SN - 1050-642X
VL - 24
SP - 96
EP - 119
JO - Clinical Journal of Sport Medicine
JF - Clinical Journal of Sport Medicine
IS - 2
ER -